Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.09%.
Coming into today, shares of the company had lost 8.68% in the past month. In that same time, the Medical sector gained 0.3%, while the S&P 500 gained 5.45%.
BNGO will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of -$0.05, up 83.33% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $2.8 million, up 145.61% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.19 per share and revenue of $16.1 million. These totals would mark changes of +51.28% and +89.32%, respectively, from last year.
Any recent changes to analyst estimates for BNGO should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company’s business outlook.